Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia

13Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Prohepcidin is one of the regulators of iron metabolism. Few studies examined its relation with solid tumors (ST), inflammatory bowel disease (IBD) and iron deficiency anemia (IDA) in children.Methods: We measured serum prohepcidin (SP), soluble transferrin receptor (sTfR), serum ferritin (SF), serum iron (SI), transferrin saturation (TS), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels in ST (n = 16), IBD (n = 15), IDA (n = 14) and controls (n = 18).Results: The mean SP was significantly higher in ST and IBD than in IDA and controls. SP was significantly correlated with SF in ST, IBD and ESR for IBD and CRP for ST and hemoglobin for ST.Conclusion: Elevated SP may be a clinically important predictor of inflammation and leads to anemia by impairing iron utilization in IBD and ST. SP decreases in IDA and is correlated with TS but not with SF or sTfR. © The Author [2010]. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Kaya, Z., Yildiz, E., Gursel, T., Albayrak, M., Kocak, U., Karadeniz, C., & Dalgiç, B. (2011). Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia. Journal of Tropical Pediatrics, 57(2), 120–125. https://doi.org/10.1093/tropej/fmq058

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free